Summary
Updated Aug 30, 2026
Bernhardt G. Zeiher is Director of Entrada Therapeutics, Inc. (TRDA). 4 SEC Form 4 filings on record, most recently on 12 June 2026. Most recent open-market trade: bought $29K of TRDA on 21 May 2026. Lifetime open-market purchases: $29K.
Recent Transactions
2Every recent SEC Form 4 transaction Bernhardt G. Zeiher has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Bernhardt G. Zeiher files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Kush Parmar - $3.65M of TRDA open-market activity in the last 12 months
- Justin B. Klee - $3.05M of AMLX open-market activity in the last 12 months
- Joshua B. Cohen - $3.04M of AMLX open-market activity in the last 12 months
- 5AM Ventures V, L.P. - $3.00M of TRDA open-market activity in the last 12 months
- BAKER BROS. ADVISORS LP - $1.61M of TRDA open-market activity in the last 12 months
- Gina Mazzariello - $866K of AMLX open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Bernhardt G. Zeiher?
Bernhardt G. Zeiher is a corporate insider, tracked as Director of Entrada Therapeutics, Inc. (TRDA). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Bernhardt G. Zeiher submitted recently?
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Has Bernhardt G. Zeiher been buying or selling stock?
Recorded transactions: 1 open-market purchase ($29K) and 0 open-market sales across all tracked filings.
Where can I see all of Bernhardt G. Zeiher's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Bernhardt G. Zeiher and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
